TheEdgeResearch
Home / Stocks / CTTH

CTT Pharmaceutical Holdings, Inc. (CTTH)

OTC Healthcare Medical - Pharmaceuticals
$0.06 ▼ -7.58%
Market Cap
$3.6M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.77
52-Wk Range
0.035-0.1
CEO
Ryan Khouri
Country
US
Currency
USD

CTT Pharmaceutical Holdings, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Tampa, FL, US. The stock last traded at $0.06, down 7.58% on the session, giving a market capitalisation of $3.6M. On trailing twelve-month figures it carries a trailing P/E of -21.79, a net margin of 0.0%. Its beta of 0.77 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-21.79
Price / Sales
0.00
Price / Book
87.26
EV / EBITDA
-33.48
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.46
Current ratio
0.20
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
1997-04-18
Headquarters
Tampa, FL, US
About CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.

Comparable companies

CTT Pharmaceutical Holdings, Inc. is most often compared with the following Healthcare names:

BINPBMCSBMMJEDXCGXXYHBRMMJNAOVATFPCYNSRUTF
More research on CTTH
CTTH technical analysis CTTH TheEdge Score Compare against peers
Open full interactive analysis & DCF →